Managing breathlessness in clinical practice

Managing Breathlessness in Clinical Practice

Volumn 9781447147541, Issue , 2014, Pages 1-265

  Booth, Sara ^a   Burkin, Julie ^a   Moffat, Catherine ^a   Spathis, Anna ^a  

^a CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84930158808     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4471-4754-1_1     Document Type: Book

References (121)

1. Moosavi S, Booth S. The genesis of breathlessness. In: Cambridge breathlessness intervention service treatment manual. Cambridge: Cambridge University Hospitals NHS Foundation Trust; 2011
2. Parshall M, Schwartzstein R, Adams L, et al. An official American thoracic society statement: update on the mechanisms, assessment and management of dypsnoea. Am J Respir Crit Care Med. 2012;185(4):435-52
3. Schon D, Rosenkranz M, Regelsberger J, et al. Reduced perception of dyspnoea and pain after right insular cortex lesion. Am J Respir Crit Care Med. 2008;178:1173-9
4. Abernethy A, McDonald C, Frith P, et al. Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind, randomised controlled trial. Lancet. 2010;376:784-93
5. Baltzan M, Alter A, Rotaple M, Kamel H, Wolkove N. Fan to palliative exercise-induced dyspnoea with severe COPD. Am J Respir Crit Care Med. 2000;161(3 Suppl):A59
6. Bausewein C, Booth S, Gysels M, Kuhnbach R, Higginson I. Effectiveness of a hand-held fan for breathlessness: a randomised phase II trial. BMC Palliat Care. 2010;9:22
7. Booth S, Kelly MJ, Cox NP, et al. Does oxygen help dyspnea in patients with cancer?. Am J Respir Crit Care Med. 1996;153:1515-8
8. Booth S, Farquhar M, Gysels M, Bausewein C, Higginson IJ. The impact of a breathlessness intervention service (BIS) on the lives of patients with intractable dyspnoea: a qualitative. Phase I study. Palliat Support Care. 2006;4:287-93
9. Farquhar M, Prevost A, McCrone P, et al. Is a specialist breathlessness service more effective for patients with advanced cancer and their carers than standard care?. Findings of a mixed method randomised controlled trial. Submitted for publication
10. Galbraith S, Fagan P, Perkins P, Lynch A, Booth S. Does the use of a handheld fan improve chronic dyspnea?. A randomised, controlled, cross-over trial. J Pain Symptom Manage. 2010;39(5):831-8
11. Liss H, Grant B. The effect of nasal flow on breathlessness in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis. 1988;137:1285-8
12. Moore R, Berlowitz D, Denehy L, et al. A randomised trial of domiciliary, ambulatory oxygen in patients with COPD and dyspnoea but without resting hypoxaemia. Thorax. 2011;66:32-7
13. Schwartzstein R, Lahive K, Pope A, et al. Cold facial stimulation reduces breathlessness induced in normal subjects. Am Rev Respir Dis. 1987;136:58-61
14. Simon P, Basner R, Weinberger S, et al. Oral mucosal stimulation modulates intensity of breathlessness induced in normal subjects. Am Rev Respir Dis. 1991;144(2):419-22
15. Spathis A, Booth S. End of life care in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2008;3(1):11-29
16. Uronis H, Currow D, McCrory D, Samsa G, Abernethy A. Oxygen for relief of dyspnoea in mildly- or non-hypoxaemic patients with cancer: a systematic review and meta-analysis. Br J Cancer. 2008;98:294-9
17. Uronis H, McCrory D, Samsa G, Currow D, Abernethy A. Symptom oxygen for non-hypoxaemic chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2011;(6); Art. No.: CD006429
18. Banzett RB, Topulos GP, Leith DE, et al. Bracing arms increases the capacity for sustained hyperpnoea. Am Rev Respir Dis. 1988;138: 106-9
19. Barach AL. Chronic obstructive lung disease: postural relief of dyspnoea. Arch Phys Med Rehabil. 1974;55:494-504
20. British Thoracic Society (BTS) & Association of Chartered Physiotherapists in Respiratory Care (ACPRC). Guidelines for the physiotherapy management of the adult, medical, spontaneously breathing patient. Thorax. 2009;64(Supplement I):i1-51
21. ONeill S, McCarthy DS. Postural relief of dyspnoea in severe chronic airflow limitation: relationship to respiratory muscle strength. Thorax. 1983;38:595-600
22. Probst VS, Trooster T, Coosemans I, Spruit MA, De Oliveira Pitta F, Decramer M, Gosselink R. Mechanisms of improvement in exercise capacity using a rollator in patients with COPD. Chest. 2004;126: 1102-7
23. Sharp JT, Drutz WS, Moisan T, et al. Postural relief of dyspnoea in severe chronic obstructive pulmonary disease. Am Rev Respir Dis. 1980;122: 201-11
24. Bradley D. Hyperventilation syndrome breathing pattern disorders and how to overcome them. London: Kyle Books; 2011
25. Bianchi R, Gigliotti F, Romagnoli I, Lanini B, Castella C, Binazzi B, et al. Patterns of chest wall kinematics during volitional pursed-lip breathing in COPD at rest. Respir Med. 2007;101(7):1412-8
26. Belman MJ, Botnick WC, Shin JW. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1996;153(3):967-75
27. Brindley J, Olive J, Godfrey K, Austin G, Shampan L . Buteyko breathing technique: teacher training manual. 3rd ed. Chipping Ongar. The Buteyko Breathing Association; 2012
28. British Thoracic Society & Association of Chartered Physiotherapists in Respiratory Care (BTS/ACPRC). Guidelines for the physiotherapy management of the adult, medical, spontaneously breathing patient. Thorax. 2009;64(Supplement I):i1-51
29. Folinsbee LJ, Wallace ES, Bedi JF, Horvath SM. Exercise respiratory pattern in elite cyclists and sedentary subjects. Med Sci Sports Exerc. 1983;15(6):503-9
30. Gosselink RA, Wagnenaar RC, Rijswijki H, et al. Diaphragmatic breathing reduces the efficiency of breathing in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1995;151:1136-42
31. Macdonald P. The Alexander technique as I see it. Brighton: Rahula Books; 1989
32. Marin JM, Carrizo SJ, Gascon M, Sanchez A, Gallego B, Celli BR. Inspiratory capacity, dynamic hyperinflation, breathlessness and exercise performance during the 6-minute-walk test in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001; 162:1395-9
33. Nield MA, Soo Hoo GW, Roper JM, Santiago S. Efficacy of pursed lips breathing: a breathing pattern retraining strategy for dyspnoea reduction. J Cardiopulm Rehabil Prev. 2007;27(4):237-44
34. Newton MF, ODonnell DE, Forkert L. Response of lung volumes to inhaled salbutamol in a large population of patients with severe hyperinflation. Chest. 2002;121(4):1042-50
35. National Institute for Health and Care Excellence (NICE). Lung cancer: the diagnosis and treatment of lung cancer. CG 121. London: National Institute for Health and Care Excellence; 2011
36. ODonnell DE. Hyperinflation, dyspnoea and exercise tolerance in COPD. Proc Am Thorac Soc. 2006;3:180-4
37. Roberts SE, Stern M, Schreuder FM, Watson T. The use of pursed lips breathing in stable chronic obstructive pulmonary disease: a systematic review of the evidence. Phys Ther Rev. 2009;14(4):240-6
38. Spahija J, Marchie M, Ghezzo H, Grassino A. Factors discriminating spontaneous pursed-lips breathing use in patients with COPD. COPD. 2010;7(4):254-61
39. Spahija J, De Marchie M, Grassino A. Effects of imposed pursed-lips breathing on respiratory mechanics and dyspnoea at rest and during exercise in COPD. Chest. 2005;128(2):640-50
40. West JB. Respiratory physiology the essentials. 8th ed. Philadelphia: Lippincott Williams & Wilkins; 2008
41. Van Der Schans CP, De Jong W, Kort E, Wijkstra PJ, Koeter GH, Postma DS, et al. Mouth pressures during pursed lip breathing. Physiother Theory Pract. 1995;11:29-34
42. Vitacca M, Clini E, Banchi L, et al. Acute effects of deep diaphragmatic breathing in COPD patients with chronic respiratory insufficiency. Eur Respir J. 1998;11:408-15
43. Banzett RB, Mulnier HE, Murphy K, Rosen SD, Wise RJ, Adams L. Breathlessness in humans activates insular cortex. Neuroreport. 2000; 11(10):2117-20
44. Bausewein C, Booth S, Gysels M, Higginson IJ. Non pharmacological interventions for breathlessness in advanced stages of malignant and nonmalignant diseases. Cochrane Database Syst Rev. 2008;(2):CD005623
45. Booth S, Moffat C, Burkin J, Galbraith S, Bausewein C. Nonpharmacological interventions for breathlessness. Curr Opin Support Palliat Care. 2011; 5(2):77-86
46. Gustavsson C, von Koch L. Applied relaxation in the treatment of longlasting neck pain: a randomized controlled pilot study. J Rehabil Med. 2006;38(2):100-7
47. Hunot V, Churchill R, Teixeira V, Silva De Lima M. Psychological Therapies for Generalised Anxiety Disorder (Review). Cochrane Collaboration. 2010;(4):CD001848
48. Kroner-Herwig B. Chronic pain syndromes and their treatment by psychological interventions. Curr Opin Psychiatry. 2009;22(2):200-4
49. Paz-Diaz H, De Oca MM, Lopez JM, Celli BR. Pulmonary rehabilitation improves depression, anxiety, dyspnea and health status in patients with COPD. Am J Phys Med Rehabil. 2007;86(1):30-6
50. Thompson B. Mindfulness-based stress reduction for people with chronic conditions. Br J Occup Ther. 2009;72(9):405-10
51. Yorke J, Fleming SL, Shuldham C Psychological Interventions for Adults with Asthma. Cochrane Collaboration. 2009;(1):CD002982
52. Booth S, Moffat C, Burkin J, Galbraith S, Bausewein C. Nonpharmacological interventions for breathlessness. Curr Opin Support Palliat Care. 2011;5(2):77-86
53. Effing T, Monninkhof EEM, Van Der Valk PP, Zielhuis GGA, Walters EH, Van Der Palen JJ, Zwerink M. Self-management education for patients with chronic obstructive pulmonary disease (Review). The Cochrane Collaboration. Issue 4; 2009:CD002990
54. Howard C, Dupont S, Haselden B, Lynch J, Wills P. The effectiveness of a group cognitive-behavioural breathlessness intervention on health status, mood and hospital admission in elderly patients with chronic obstructive pulmonary disease. Psychol Health Med. 2010;15(4): 371-85
55. McCracken LM, Samuel VM. The role of avoidance, pacing and other activity patterns in chronic pain. Pain. 2007;130(1-2):119-25
56. Payne C, Wiffen PJ, Martin S. Interventions for fatigue and weight loss in adults with advanced progressive illness (Review). The Cochrane Collaboration. Issue 8; 2012:CD008427
57. Paz-Diaz H, De Oca MM, Lopez JM, Celli BR. Pulmonary rehabilitation improves depression, anxiety, dyspnea and health status in patients with COPD. Am J Phys Med Rehabil. 2007;86(1):30-6
58. American College of Sports Medicine (ACSM). American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc. 2010;42(7):1409-26
59. American Thoracic Society & European Respiratory Society (ATS/ERS). American Thoracic Society and European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med. 2006;173: 1390-413
60. Be Active Ltd. Pedometer walking programme advice leaflet. 2009. www.be-activeltd.co.uk
61. Benton MJ, Swan PD. Addition of resistance training to pulmonary rehabilitation programme: an evidence-based rational ad guidelines for use of resistance training with elderly patients with COPD. Cardiopulm Phys Ther J. 2006;17(4):127-33
62. Borg GA. Psychophysiological bases of perceived exertion. Med Sci Sports Exerc. 1982;14:377-81
63. British Thoracic Society (BTS) & Association of Chartered Physiotherapists in Respiratory Care (ACPRC). Guidelines for the physiotherapy management of the adult, medical, spontaneously breathing patient. Thorax. 2009;64(I):i1-51
64. British Thoracic Society (BTS) & Scottish Intercollegiate Guidelines Network (SIGN). 101 British guideline on the management of asthma: a national clinical guideline. 2012. www.brit-thoracic.org.uk
65. Campbell A, Foster J, Stevinson C, Cavill N. The importance of physical activity for people living with and beyond cancer: a concise evidence review. London: Macmillan Cancer Support; 2012. http://www.macmillan.org.uk/Documents/AboutUs/Commissioners/Physicalactivityevidencereview.pdf
66. Celli BR. Exercise in the rehabilitation of patients with respiratory disease. In: Hodgkin JE, Celli BR, Connors GL, editors. Pulmonary rehabilitation: guidelines to success. 4th ed. St Louis: Mosby Elsevier; 2009. p. 129-42
67. Department of Health. Start active, stay active: a report on physical activity from the four home countries chief medical officers. London. 2011
68. England R, Maddocks M, Manderson C, Wilcock A. Factors influencing exercise performance in thoracic cancer. Respir Med. 2012;106(2):294-9
69. Evans RA, Singh SJ, Morgan MD. A randomised controlled trial of pulmonary rehabilitation for patients with chronic heart failure. Eur Respir J. 2007;28(S50):766s
70. Gosselink R, De Vos J, van Den Heuvel SP, Segers J, Decramer M, Kwakkel G. Impact of inspiratory muscle training in patients with COPD: what is the evidence?. Eur Respir J. 2011;37(2):416-25
71. Heppner PS, Morgan C, Kaplan RM, Ries AL. Regular walking and long-term maintenance of outcomes after pulmonary rehabilitation. J Cardiopulm Rehabil. 2006;26(1):44-53
72. Morris GS, Gallagher GH, Baxter MF, Brueilly KE, Scheetz JS, Amhed MM, Shannon VR. Pulmonary rehabilitation improves functional status in oncology patients. Arch Phy Med Rehabil. 2009;90(5): 837-41
73. National Clinical Guideline Centre. Chronic obstructive pulmonary disease: management of chronic obstructive pulmonary disease in adults in primary and secondary care. London: National Clinical Guideline Centre; 2010. Available at http://guidance.nice.org.uk/CG101/Guidance/pdf/English
74. National Institute for Health and Clinical Excellence (NICE). Idiopathic pulmonary fibrosis: the diagnosis and management of suspected idiopathic pulmonary fibrosis. NICE clinical guideline 163. 2013. www. nice.org.uk
75. National Institute for Health and Clinical Excellence (NICE). Chronic heart failure: management of chronic heart failure in adults in primary and secondary care. NICE clinical guideline 108. 2010. www. nice.org.uk
76. OShea SD, Taylor NF, Paratz J. Peripheral muscle strength training in COPD: a systematic review. Chest. 2004;126:903-14
77. Puente-Maestu L, Sanx ML, Sanx P, et al. Comparison of effects of a supervised vs self monitored training programme in patients with chronic obstructive pulmonary disease. Eur Respir J. 2000;15(3): 517-25
78. Speck R, Courneya K, Masse L, Duval S, Schmitz K. An update of controlled physical activity trials in cancer survivors: a systematic review. J Cancer Surviv. 2010;4:87-100
79. Spence RR, Heesch KC, Brown WJ. Exercise and cancer rehabilitation: a systematic review. Cancer Treat Rev. 2010;36:185-94
80. Steel BG, Belza B, Cain K, Coppersmith J, Howard J, Lakshminarayan S, Haselkorn J. The impact of chronic obstructive pulmonary disease exacerbation on pulmonary rehabilitation participation and functional outcomes. J Cardiopulm Rehabil. 2010;30(1):53-60
81. Booth S, Silverster S, Todd C. Breathlessness in cancer and chronic obstructive pulmonary disease: using a qualitative approach to describe the experience of patients and carers. Palliat Suppor Care. 2003;1:337-44
82. Candy B, Jones L, Drake R, Leurent B, King M. (2011) Interventions for supporting informal caregivers of patients in the terminal phase of a disease. Cochrane Database Syst Rev. (6):CD007617
83. Currow D, Ward A, Clark K, Burns C, Abernathy A. Caregivers for people with end-stage lung disease: characteristics and unmet needs in the whole population. Int J Chron Obstruct Pulmon Dis. 2008;3(4): 753-62
84. Curt GA, Breitbart W, Cella D, Groopman JE, Horning SJ, Itri LM, Johnson DH, Miaskowski C, Scherr SL, Portenoy RK, Vogelzang NJ. Impact of cancer-related fatigue on the lives of patients: new findings from the fatigue coalition. Oncologist. 2000;5:353-60
85. Farquhar M, Higginson IJ, Fagan P, Booth S. Results of a pilot investigation into a complex intervention for breathlessness in advanced chronic obstructive pulmonary disease (COPD): brief report. Palliat Support Care. 2010;8:143-9
86. McNamara B, Rosenwax L. Which carers of family members at the end of life need more support from health services and why?. Soc Sci Med. 2010;70:1035-41
87. Vernooij-Dassen M, Draskovic I, McCleery J, Downs M. (2011) Cognitive reframing for carers of people with dementia (Review). Cochrane Database Syst Rev. (11):CD005318
88. Abernethy AP, Currow DC, Frith P, Fazekas BS, McHugh A, Bui C. Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea. BMJ. 2003;327(7414):523-8
89. Jennings AL, Davies AN, Higgins JP, Gibbs JS, Broadley KE. A systematic review of the use of opioids in the management of dyspnoea. Thorax. 2002;57(11):939-44
90. Simon ST, Higginson IJ, Booth S, Harding R, Bausewein C. Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults (Review). 2010. The Cochrane Collaboration. Published by JohnWiley & Sons, Ltd
91. Booth S, Bausewein C, Higginson I, Moosavi SH. Pharmacological treatment of refractory breathlessness. Expert Rev Respir Med. 2009; 3(1):21-36
92. Currow DC, McDonald C, Oaten S, Kenny B, Allcroft P, Frith P, Briffa M, Johson MJ, Abernethy AP. Once-daily opioids for chronic dyspnea: a dose increment and pharmacovigilance study. J Pain Symptom Manage. 2011;42(3):388-99
93. Davenport PW, Vovk A. Cortical and subcortical central neural pathways in respiratory sensations. Respir Physiol Neurobiol. 2009; 167(1):72-86
94. Johnson MJ, Abernethy AP, Currow DC. Gaps in the evidence base of opioids for refractory breathlessness. A future work plan?. J Pain Symptom Manage. 2012;43(3):614-24
95. Mahler DA. Opioids for refractory dyspnea. Expert Rev Respir Med. 2013;7(2):123-35
96. Rocker G, Young J, Donahue M, Farquhar M, Simpson C. Perspectives of patients, family caregivers and physicians about the use of opioids for refractory dyspnea in advanced chronic obstructive pulmonary disease. CMAJ. 2012;184(9):E497-504
97. Booth S. End of life care for the breathless patient. Gen Pract. 2009;39-43
98. Burge A, Lee A, Nicholes A, et al. Advance care planning education in pulmonary rehabilitation: a qualitative study exploring participant perspectives. Palliat Med. 2013;27(6):508-15
99. Davison S, Simpson C. Hope and advance care planning in patients with end stage renal disease: qualitative interview study. Br Med J. 2006;333(7574):886. doi: 10.1136/bmj.38965.626250.55
100. Debate of the Age Health and Care Study Group. The future of health and care of older people: the best is yet to come. London: Age Concern; 1999
101. Detering K, Hancock A, Reade M, Silvester W. The impact of advance care planning on end of life care in elderly patient: randomised controlled trial. Br Med J. 2010;340:c1345. doi: 10.1136/bmj.c1345
102. Heffner JE, Fahy B, Hilling L, et al. Attitudes regarding advance directives among patients in pulmonary rehabilitation. Am J Respir Crit Care Med. 1996;154:1735-40
103. Nishimura K, Izumi R, Tsukino M, Oga T. Dyspnoea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest. 2002;121(5):1434-40
104. Seal M. Patient advocacy and advance care planning in the acute hospital setting. Aust J Adv Nurs. 2007;24(4):29-36
105. Spathis A, Booth S. End of life care in chronic obstructive pulmonary disease: in search of a good death. Int J Chron Obstruct Pulmon Dis. 2008;3(1):11-29
106. Steer J, Norman E, Afolabi O, Gibson G, Bourke S. Dsypnoea severity and pneumonia as predictors of in-hospital mortality and early readmission in acute exacerbations of COPD. Thorax. 2011;67(2):117-21
107. Wright A, Zhang B, Ray A, et al. Associations between end of life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment. JAMA. 2008;300(14):1665-73
108. Ahmedzai S, Currow D, Baldwin D. Supportive care in respiratory disease. 2nd ed. Oxford: OUP; 2012
109. Booth S, Silvester S, Todd CJ. Breathlessness in cancer and chronic obstructive pulmonary disease: using a qualitative approach to describe the experience of patients and carers. Palliat Support Care. 2003;1:337-44
110. Booth S, Bausewein C, Rocker G. New models of care for advanced lung disease. Prog Palliat Care. 2011a;19(5):254-63
111. Booth S, Moffat C, Burkin J, Galbraith S, Bausewein C. Non pharmacological interventions for breathlessness. Curr Opin Support Palliat Care. 2011b;5(2):77-86
112. Booth S, Moffat C, Farquhar M, Higginson IJ, Burkin J. Developing a breathlessness intervention service for patients with palliative and supportive care needs, irrespective of diagnosis. J Palliat Care. 2011c;27(1):28-36
113. Booth S. The wellbeing diary. Cambridge: Addenbrookes Palliative Care Service and the Fitzwilliam Museum; Dandelion Clock, 2013a
114. Booth S. Science supporting the art of medicine; improving the management of breathlessness. Palliat Med. 2013b;27(6):483-5
115. Farquhar M, Prevost AT, McCrone P, Higginson IJ, Gray J, Brafman- Kennedy B, Booth S. Study protocol: phase III single-blinded fasttrack pragmatic randomised controlled trial of a complex intervention for breathlessness in advanced disease. Trials. 2011;12:130
116. Gracely RH, Undem BJ and Banzett RB. Cough, pain and dyspnoea: similarities and differences. Pulm Pharmacol Ther. 2007;20(4):433-437
117. Johnson MJ, Booth S. Palliative and end of life care for patients with chronic heart failure and chronic lung disease. Clin Med. 2010;10(3):1-4
118. Spathis A, Davies HE, Booth S. Respiratory disease; from advanced disease to bereavement. Oxford: OUP; 2011
119. Booth S, Farquhar M, Gysels M, Bausewein C, Higginson I. The impact of a breathlessness intervention service (BIS) on the lives of patients with intractable dyspnoea: a qualitative phase 1 study. Palliat Support Care. 2006;4:287-93
120. Foresight Mental Capital and Wellbeing Project. Final project report - executive summary. London: The Government Office for Science; 2008
121. Wellbeing Postcards reproduced with permission of the Government Office for Science and the nef (new economics foundation), London